Uriel Pérez
Uriel Pérez is the director of the National Pharmacy and Drugs Directorate at the Ministry of Health in Panama. He has been actively involved in the implementation of new regulations concerning food and drug safety, particularly overseeing the transition away from the use of the controversial colorant Red No. 3 in pharmaceuticals.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Panama | 1 | 7.00 | 1.00% | +0% | 4,314,768 | 43,148 | $76,000 | 760$ |
| Totals | 1 | 4,314,768 | 43,148 | $76,000 | 760$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Panama:
Uriel Pérez is the national director of Pharmacy and Drugs who explained the preventive actions taken by the Minsa regarding cosmetic products.
7
Panama:
Uriel Pérez explained that, in this first stage, only products with CBD will be marketed under medical prescription.
7
Panama:
Uriel Pérez explained that the commercialization of medicinal cannabis will be carried out in phases.
7
Panama:
Uriel Pérez is the national director of Pharmacy and Drugs at the Ministry of Health (Minsa) who responded to concerns about biotechnological regulations.
7
Panama:
Uriel Pérez is the director of Pharmacies and Drugs at the Ministry of Health who announced progress in the availability of cannabis products.
6
Panama:
Uriel Pérez is the national director of Pharmacy and Drugs who confirmed the progress in implementing the cannabis law.
8
Panama:
Uriel Pérez is the national director of Pharmacy and Drugs at the Ministry of Health in Panama.
7
Panama:
Uriel Pérez indicated that the interpretation of the Minsa is that while a research protocol is approved by a Bioethics Committee, it does not contravene what is established in the article.
5
Panama:
Uriel Pérez, director de Farmacia y Drogas, aclaró que no existe ninguna alarma sobre la aplicación de la vacuna contra la covid-19.
7
Panama:
Uriel Pérez, director of the Dirección Nacional de Farmacia y Drogas del Minsa, explained the FDA alert regarding the risks of weight loss in young patients taking metilfenidato.
7